XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Jun. 30, 2021
Dec. 31, 2020
Current Assets    
Cash and cash equivalents $ 8,575 $ 8,050
Accounts receivable (net of allowance for doubtful accounts of $72 in 2021 and $67 in 2020) 7,843 6,803
Inventories (excludes inventories of $2,412 in 2021 and $2,070 in 2020 classified in Other assets - see Note 7) 5,499 5,554
Other current assets 6,748 4,674
Current assets of discontinued operations 0 2,683
Total current assets 28,665 27,764
Investments 411 785
Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,236 in 2021 and $18,162 in 2020 18,064 17,000
Goodwill 18,873 18,882
Other Intangibles, Net 13,622 14,101
Other Assets 11,053 9,881
Noncurrent Assets of Discontinued Operations 0 3,175
Total Assets 90,688 91,588
Current Liabilities    
Loans payable and current portion of long-term debt 2,488 6,431
Trade accounts payable 3,897 4,327
Accrued and other current liabilities 12,888 12,212
Income taxes payable 971 1,597
Dividends payable 1,662 1,674
Current liabilities of discontinued operations 0 1,086
Total current liabilities 21,906 27,327
Long-Term Debt 24,033 25,360
Deferred Income Taxes 1,489 1,005
Other Noncurrent Liabilities 9,872 12,306
Noncurrent Liabilities of Discontinued Operations 0 186
Merck & Co., Inc. Stockholders’ Equity    
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2021 and 2020 1,788 1,788
Other paid-in capital 44,039 39,588
Retained earnings 48,777 47,362
Accumulated other comprehensive loss (4,628) (6,634)
Stockholders' equity before deduction for treasury stock 89,976 82,104
Less treasury stock, at cost: 1,044,351,147 shares in 2021 and 1,046,877,695 shares in 2020 56,682 56,787
Total Merck & Co., Inc. stockholders’ equity 33,294 25,317
Noncontrolling Interests 94 87
Total equity 33,388 25,404
Liabilities and Equity $ 90,688 $ 91,588